Sai Med Pharma Systems Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.54 Cr
- Company Age 30 Year, 13 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.95 M
- Satisfied Charges ₹ 2.00 M
- Revenue Growth -22.20%
- Profit Growth -22.51%
- Ebitda -25.40%
- Net Worth 30.34%
- Total Assets -45.19%
About Sai Med Pharma Systems
Sai Med Pharma Systems Private Limited (SMPSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 18 January 1995 and has a history of 30 years. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.54 Cr.
The company currently has active open charges totaling ₹9.95 M. The company has closed loans amounting to ₹2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Padmanabhuni Sanjay and Padmanabhuni Appaji serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24239TG1995PTC019231
- Company No.
019231
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sai Med Pharma Systems?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Padmanabhuni Appaji | Director | 05-Jan-2011 | Current |
Padmanabhuni Sanjay | Director | 18-Jan-1995 | Current |
Financial Performance of Sai Med Pharma Systems.
Sai Med Pharma Systems Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 22.2% decrease. The company also saw a substantial fall in profitability, with a 22.51% decrease in profit. The company's net worth Soared by an impressive increase of 30.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Sai Med Pharma Systems?
In 2023, Sai Med Pharma Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.00 Cr
₹0.20 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.61 Cr
- State Bank Of Bikaner & Jaipur : 0.39 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
03 Jul 2021 | Hdfc Bank Limited | ₹6.05 M | Open |
18 Mar 1999 | State Bank Of Bikaner & Jaipur | ₹3.90 M | Open |
16 Oct 1997 | The Lakshmi Vilas Bank Ltd | ₹1.00 M | Satisfied |
17 Jul 1997 | The Lakshmi Vilas Bank Ltd | ₹1.00 M | Satisfied |
How Many Employees Work at Sai Med Pharma Systems?
Sai Med Pharma Systems has a workforce of 4 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sai Med Pharma Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sai Med Pharma Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.